To address more recently circulating coronavirus strains, advisors to the U.S. Food and Drug Administration recently suggested altering the design of COVID-19 booster doses this fall. The next round of COVID booster shots should contain a component that combats the Omicron strain of the coronavirus, according to a 19–2 vote by the FDA’s Advisory Committee on […]
The post US FDA Advisers Advocate Changing Fall COVID Vaccine Dosage first appeared on World Pharma Today.This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here